[1]Locationinpatent:experimentalpartKraus,GeorgeA.;Gupta,Vinayak;Mokhtarian,Marjan;Mehanovic,Samir;Nilsen-Hamilton,Marit[BioorganicandMedicinalChemistry,2010,vol.18,#17,p.6316-6321]
[2]Zhang,Jing;Lu,Dai;Wei,Han-Xun;Gu,Yongli;Selkoe,DennisJ.;Wolfe,MichaelS.;Augelli-Szafran,CorinneE.[BioorganicandMedicinalChemistryLetters,2016,vol.26,#9,p.2138-2141]
[1]Zhang,Jing;Lu,Dai;Wei,Han-Xun;Gu,Yongli;Selkoe,DennisJ.;Wolfe,MichaelS.;Augelli-Szafran,CorinneE.[BioorganicandMedicinalChemistryLetters,2016,vol.26,#9,p.2138-2141]
[2]Zhang,Jing;Lu,Dai;Wei,Han-Xun;Gu,Yongli;Selkoe,DennisJ.;Wolfe,MichaelS.;Augelli-Szafran,CorinneE.[BioorganicandMedicinalChemistryLetters,2016,vol.26,#9,p.2138-2141]
[1]BioorganicandMedicinalChemistryLetters,2016,vol.26,p.2138-2141
[2]BioorganicandMedicinalChemistryLetters,2016,vol.26,p.2138-2141
[1]Zhang,Jing;Lu,Dai;Wei,Han-Xun;Gu,Yongli;Selkoe,DennisJ.;Wolfe,MichaelS.;Augelli-Szafran,CorinneE.[BioorganicandMedicinalChemistryLetters,2016,vol.26,#9,p.2138-2141]
[2]Zhang,Jing;Lu,Dai;Wei,Han-Xun;Gu,Yongli;Selkoe,DennisJ.;Wolfe,MichaelS.;Augelli-Szafran,CorinneE.[BioorganicandMedicinalChemistryLetters,2016,vol.26,#9,p.2138-2141]
[1]Zhang,Jing;Lu,Dai;Wei,Han-Xun;Gu,Yongli;Selkoe,DennisJ.;Wolfe,MichaelS.;Augelli-Szafran,CorinneE.[BioorganicandMedicinalChemistryLetters,2016,vol.26,#9,p.2138-2141]
Title: Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3.
Journal: Journal of medicinal chemistry 20131024
Title: Comprehensive analysis of kinase inhibitor selectivity.
Journal: Nature biotechnology 20111030
Title: Activation state-dependent binding of small molecule kinase inhibitors: structural insights from biochemistry.
Journal: Chemistry & biology 20101124
Title: New effective inhibitors of the Abelson kinase.
Journal: Bioorganic & medicinal chemistry 20100901
Title: A bead-based activity screen for small-molecule inhibitors of signal transduction in chronic myelogenous leukemia cells.
Journal: Molecular cancer therapeutics 20100501
Title: Induced disorder in protein-ligand complexes as a drug-design strategy.
Journal: Molecular pharmaceutics 20080101
Title: Structural insights into the ATP binding pocket of the anaplastic lymphoma kinase by site-directed mutagenesis, inhibitor binding analysis, and homology modeling.
Journal: Journal of medicinal chemistry 20060921
Title: Phosphorylation of IkappaB-beta is necessary for neuronal survival.
Journal: The Journal of biological chemistry 20060120
Title: Inhibition of wild-type and mutant Bcr-Abl by AP23464, a potent ATP-based oncogenic protein kinase inhibitor: implications for CML.
Journal: Blood 20041015
Title: Direct evidence that Bcr-Abl tyrosine kinase activity disrupts normal synergistic interactions between Kit ligand and cytokines in primary primitive progenitor cells.
Journal: Molecular cancer research : MCR 20030101
Title: Src activation regulates anoikis in human colon tumor cell lines.
Journal: Oncogene 20021107
Title: Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571).
Journal: Cancer research 20020801
Title: Characterization of potent inhibitors of the Bcr-Abl and the c-kit receptor tyrosine kinases.
Journal: Cancer research 20020801
Title: Moasser MM, et al. Inhibition of Src kinases by a selective tyrosine kinase inhibitor causes mitotic arrest. Cancer Res. 1999 Dec 15;59(24):6145-52.
Title: Kraus GA, et al. New effective inhibitors of the Abelson kinase. Bioorg Med Chem. 2010 Sep 1;18(17):6316-21.
Title: Windham TC, et al. Src activation regulates anoikis in human colon tumor cell lines. Oncogene. 2002 Nov 7;21(51):7797-807.
